BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31567982)

  • 21. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma.
    Guan Z; Zhang J; Wang J; Wang H; Zheng F; Peng J; Xu Y; Yan M; Liu B; Cui B; Huang Y; Liu Q
    Mol Cancer; 2014 Nov; 13():257. PubMed ID: 25427424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
    Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
    Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
    Li M; Li O; Sun J; Zheng X; Ma D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
    [No Abstract]   [Full Text] [Related]  

  • 25. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population.
    Rizvi MM; Alam MS; Ali A; Mehdi SJ; Batra S; Mandal AK
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1255-62. PubMed ID: 21698421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
    Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
    Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
    Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
    Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT
    Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
    Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.
    Fujimoto T; Nishikawa A; Iwasaki M; Akutagawa N; Teramoto M; Kudo R
    Gynecol Oncol; 2004 May; 93(2):446-53. PubMed ID: 15099960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Villin1, a novel diagnostic marker for cervical adenocarcinoma.
    Nakamura E; Iwakawa M; Furuta R; Ohno T; Satoh T; Nakawatari M; Ishikawa K; Imadome K; Michikawa Y; Tamaki T; Kato S; Kitagawa T; Imai T
    Cancer Biol Ther; 2009 Jun; 8(12):1146-53. PubMed ID: 19377296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
    Cocco E; Varughese J; Buza N; Bellone S; Glasgow M; Bellone M; Todeschini P; Carrara L; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Lockwood CJ; Santin AD
    BMC Cancer; 2011 Jun; 11():263. PubMed ID: 21693061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
    Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
    Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
    Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
    Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant DNA methylation of apoptotic signaling genes in patients responsive and nonresponsive to therapy for cervical carcinoma.
    Chaopatchayakul P; Jearanaikoon P; Yuenyao P; Limpaiboon T
    Am J Obstet Gynecol; 2010 Mar; 202(3):281.e1-9. PubMed ID: 20117760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.
    Ivanova T; Petrenko A; Gritsko T; Vinokourova S; Eshilev E; Kobzeva V; Kisseljov F; Kisseljova N
    BMC Cancer; 2002 Mar; 2():4. PubMed ID: 11945179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
    Liu FS; Chen JT; Dong JT; Hsieh YT; Lin AJ; Ho ES; Hung MJ; Lu CH
    Am J Pathol; 2001 Nov; 159(5):1629-34. PubMed ID: 11696423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel genetic and epigenetic regulators of different tissue types of cervical cancer.
    Chandra S; Sarkar S; Mandal P
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3179-3190. PubMed ID: 36184073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
    Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
    Yang WT; Zheng PS
    PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.